• Company
• Lorviqua can be prescribed at general hospitals
• by Eo, Yun-Ho Feb 4, 2022 05:57am

• Opinion
• [Reporter’s View] Mutual understanding is required
• by Kim, Jin-Gu Feb 4, 2022 05:57am

• Company
• SK Bioscience appoints former BMS lead Pa-leun Kim as VP
• by Eo, Yun-Ho Feb 4, 2022 05:57am

• Policy
• Janssen Korea has obtained permission
• by Lee, Tak-Sun Feb 4, 2022 05:56am

• Company
• Organon Korea's Cozaar XQ will be resupplied
• by Feb 4, 2022 05:56am

• Company
• Sales of Statin/Ezetimibe have surpassed ₩600 billion
• by Chon, Seung-Hyun Feb 3, 2022 05:57am

• InterView
• Era of ₩30 bil novel homegrown drug Suganon begins now
• by Feb 3, 2022 05:57am

• Policy
• 45 generics of Dapagliflozin+Sitagliptin were approved
• by Lee, Tak-Sun Feb 3, 2022 05:57am

• Company
• Hepatitis C market in decline due to superior treatment
• by Ji Yong Jun Feb 3, 2022 05:56am

• Company
• Competition in the narcolepsy tx market is expected
• by Eo, Yun-Ho Feb 3, 2022 05:56am